Related Experiment Video

Updated: Nov 7, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.3K

Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease

Katherine Driscoll1, Alexander D Cruz1, Jonathan T Butcher1

  • 1Meinig School of Biomedical Engineering, Cornell University, Ithaca NY.

Circulation Research
|April 29, 2021
PubMed

Insights

Calcific aortic valve disease (CAVD) lacks effective therapies beyond valve replacement. Understanding CAVD mechanisms is crucial for developing new treatments to help younger patients.

Area of Science:

  • Cardiovascular Research
  • Biomaterials Science
  • Translational Medicine

Background:

  • Calcific aortic valve disease (CAVD) presents a growing global health challenge.
  • Current treatment options for CAVD are limited to surgical or transcatheter prosthetic valve replacement.
  • There is a critical need for alternative therapies, especially for a growing population of younger, active patients.

Purpose of the Study:

  • To investigate the underlying mechanisms of CAVD initiation and progression.
  • To identify potential targets for novel, biologically based diagnostics and therapeutics.
  • To explore strategies for delaying or alleviating CAVD progression.

Main Methods:

  • Review of existing literature on CAVD pathogenesis.
  • Analysis of cellular and molecular pathways involved in valve calcification.
  • Exploration of potential biomarkers for early diagnosis and disease monitoring.

Main Results:

  • Limited understanding of complex CAVD mechanisms hinders therapeutic development.
  • A significant gap exists between current knowledge and clinically applicable interventions.
  • Early intervention strategies may be possible if disease pathways are better elucidated.

Conclusions:

  • Further research into the intricate mechanisms of CAVD is essential.
  • Developing non-prosthetic therapies is a priority for managing this increasing disease burden.
  • Targeting early disease processes could offer new avenues for treatment and prevention.

Keywords:
aortic valvecardiovascular diseasecytokinesendothelial cellsinflammation

More Related Videos

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.5K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

3.0K

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
315
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
148
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
141
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
115